News
Media
Conferences
CME/CE
Partners
Publications
Resources
Subscribe

LEMS

CME Content

Increasing Awareness of Therapeutic Options for Thymidine Kinase 2 Deficiency (TK2d)

Increasing Awareness of Therapeutic Options for Thymidine Kinase 2 Deficiency (TK2d)

Michio Hirano, MD; Mary Kay Koenig, MD; Zarazuela Zolkipli-Cunningham, MBChB, MRCP

How Do I Identify MOGAD? Improving Outcomes Through Early Identification of Patients

How Do I Identify MOGAD? Improving Outcomes Through Early Identification of Patients

Michael Levy, MD, PhD; Jeffrey L. Bennett, MD, PhD; Eoin P. Flanagan, MB, BCh

Please check back later for more content.

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

FDA Grants Priority Review to Huntington Disease Gene Therapy BLA

Brezosiran Demonstrates Mutant Huntingtin Reduction in Phase 1b Huntington Disease Study

AL-S Pharma Details Planned Phase 3 Trial Design for AP-101 in ALS

Alzheimer Agent Sabirnetug Misses Primary Endpoint, Acumen Halts Development

Zola-Cel and Treatment-Free Remission: What the BREAKFREE-2 Data Show